Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment.

Despierre E, Lambrechts D, Neven P, Amant F, Lambrechts S, Vergote I.

Gynecol Oncol. 2010 May;117(2):358-65. doi: 10.1016/j.ygyno.2010.02.012. Epub 2010 Mar 7. Review.

PMID:
20207398
[PubMed - indexed for MEDLINE]
2.

Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Roukos DH.

Expert Rev Mol Diagn. 2010 Jan;10(1):33-48. doi: 10.1586/erm.09.69. Review.

PMID:
20014921
[PubMed - indexed for MEDLINE]
3.

Apply innovative technologies to explore cancer genome.

Shih IeM, Wang TL.

Curr Opin Oncol. 2005 Jan;17(1):33-8. Review.

PMID:
15608510
[PubMed - indexed for MEDLINE]
4.

High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications.

Gorringe KL, Jacobs S, Thompson ER, Sridhar A, Qiu W, Choong DY, Campbell IG.

Clin Cancer Res. 2007 Aug 15;13(16):4731-9.

PMID:
17699850
[PubMed - indexed for MEDLINE]
Free Article
5.

Genetic analysis of cancer-implicated MicroRNA in ovarian cancer.

Bearfoot JL, Choong DY, Gorringe KL, Campbell IG.

Clin Cancer Res. 2008 Nov 15;14(22):7246-50. doi: 10.1158/1078-0432.CCR-08-1348.

PMID:
19010840
[PubMed - indexed for MEDLINE]
Free Article
6.

Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer.

Roukos DH, Murray S, Briasoulis E.

Cancer Biol Ther. 2007 Mar;6(3):308-12. Epub 2007 Mar 9. Review.

PMID:
17387266
[PubMed - indexed for MEDLINE]
Free Article
7.

Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer.

Bowcock AM.

Breast Cancer Res Treat. 1993 Nov;28(2):121-35. Review.

PMID:
8173065
[PubMed - indexed for MEDLINE]
8.

Genomic tests for ovarian cancer detection and management.

Myers ER, Havrilesky LJ, Kulasingam SL, Sanders GD, Cline KE, Gray RN, Berchuck A, McCrory DC.

Evid Rep Technol Assess (Full Rep). 2006 Oct;(145):1-100. Review.

PMID:
17764207
[PubMed - indexed for MEDLINE]
Free Article
9.

The molecular basis of ovarian cancer.

Gallion HH, Pieretti M, DePriest PD, van Nagell JR Jr.

Cancer. 1995 Nov 15;76(10 Suppl):1992-7. Review.

PMID:
8634990
[PubMed - indexed for MEDLINE]
10.

Genomic analysis of epithelial ovarian cancer.

Farley J, Ozbun LL, Birrer MJ.

Cell Res. 2008 May;18(5):538-48. doi: 10.1038/cr.2008.52. Review.

PMID:
18427574
[PubMed - indexed for MEDLINE]
Free Article
11.

Analysis of molecular aberrations in ovarian cancer allows novel target identification.

Cheng KW, Lahad JP, Mills GB.

J Obstet Gynaecol Can. 2004 May;26(5):461-74. Review.

PMID:
15151733
[PubMed - indexed for MEDLINE]
12.

[Cancer genome analysis through next-generation sequencing].

Aburatani H.

Gan To Kagaku Ryoho. 2011 Jan;38(1):1-6. Review. Japanese.

PMID:
21368453
[PubMed - indexed for MEDLINE]
13.

Diverse molecular pathways in ovarian cancer and their clinical significance.

Ricciardelli C, Oehler MK.

Maturitas. 2009 Mar 20;62(3):270-5. doi: 10.1016/j.maturitas.2009.01.001. Epub 2009 Feb 3. Review.

PMID:
19193504
[PubMed - indexed for MEDLINE]
14.

Epigenetics of ovarian cancer: from the lab to the clinic.

Asadollahi R, Hyde CA, Zhong XY.

Gynecol Oncol. 2010 Jul;118(1):81-7. doi: 10.1016/j.ygyno.2010.03.015. Epub 2010 Apr 24. Review.

PMID:
20421130
[PubMed - indexed for MEDLINE]
15.

Large-scale genomic analysis of ovarian carcinomas.

Gorringe KL, Campbell IG.

Mol Oncol. 2009 Apr;3(2):157-64. doi: 10.1016/j.molonc.2008.12.005. Epub 2008 Dec 24. Review.

PMID:
19383377
[PubMed - indexed for MEDLINE]
Free Article
16.

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng DH, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright L, Steele L, Offit K, Thomas A, et al.

JAMA. 1997 Oct 15;278(15):1242-50.

PMID:
9333265
[PubMed - indexed for MEDLINE]
17.

Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours.

Khalique L, Ayhan A, Weale ME, Jacobs IJ, Ramus SJ, Gayther SA.

J Pathol. 2007 Feb;211(3):286-95.

PMID:
17154249
[PubMed - indexed for MEDLINE]
18.

Ovarian cancer: markers of response.

Na YJ, Farley J, Zeh A, del Carmen M, Penson R, Birrer MJ.

Int J Gynecol Cancer. 2009 Dec;19 Suppl 2:S21-9. doi: 10.1111/IGC.0b013e3181c2aeb5. Review.

PMID:
19955910
[PubMed - indexed for MEDLINE]
19.

[Clinical and molecular diagnosis of inherited breast-ovarian cancer].

Chompret A.

J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19. Review. French.

PMID:
12717301
[PubMed - indexed for MEDLINE]
Free Article
20.

BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.

Ramus SJ, Pharoah PD, Harrington P, Pye C, Werness B, Bobrow L, Ayhan A, Wells D, Fishman A, Gore M, DiCioccio RA, Piver MS, Whittemore AS, Ponder BA, Gayther SA.

Cancer Res. 2003 Jan 15;63(2):417-23.

PMID:
12543797
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk